- Home
- ALCE vs SCNI Comparison
ALCE vs SCNI Comparison
Compare ALCE & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALCE
- SCNI
- Stock Information
- Founded
- ALCE 2019
- SCNI 2003
- Country
- ALCE United States
- SCNI Israel
- Employees
- ALCE N/A
- SCNI N/A
- Industry
- ALCE Power Generation
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALCE Utilities
- SCNI Health Care
- Exchange
- ALCE Nasdaq
- SCNI Nasdaq
- Market Cap
- ALCE 3.7M
- SCNI 3.5M
- IPO Year
- ALCE N/A
- SCNI N/A
- Fundamental
- Price
- ALCE $0.80
- SCNI $3.48
- Analyst Decision
- ALCE
- SCNI
- Analyst Count
- ALCE 0
- SCNI 0
- Target Price
- ALCE N/A
- SCNI N/A
- AVG Volume (30 Days)
- ALCE 674.0K
- SCNI 13.2K
- Earning Date
- ALCE 11-19-2024
- SCNI 11-22-2024
- Dividend Yield
- ALCE N/A
- SCNI N/A
- EPS Growth
- ALCE N/A
- SCNI N/A
- EPS
- ALCE N/A
- SCNI 8.20
- Revenue
- ALCE N/A
- SCNI $452,000.00
- Revenue This Year
- ALCE N/A
- SCNI N/A
- Revenue Next Year
- ALCE N/A
- SCNI N/A
- P/E Ratio
- ALCE N/A
- SCNI $0.42
- Revenue Growth
- ALCE N/A
- SCNI N/A
- 52 Week Low
- ALCE $0.74
- SCNI $2.23
- 52 Week High
- ALCE $162.75
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- ALCE 22.06
- SCNI 56.32
- Support Level
- ALCE $0.98
- SCNI $3.20
- Resistance Level
- ALCE $1.23
- SCNI $3.55
- Average True Range (ATR)
- ALCE 0.11
- SCNI 0.18
- MACD
- ALCE 0.02
- SCNI 0.03
- Stochastic Oscillator
- ALCE 4.29
- SCNI 51.72
About ALCE Alternus Clean Energy Inc.
Alternus Clean Energy Inc is an international independent clean energy producer. It develops, installs, owns and operates a diverse portfolio of utility-scale solar photovoltaic power stations (PV parks) in Europe and the USA as a long-term owner. The solar parks benefit from long-term government offtake contracts and/or Power Purchase Agreements (PPAs) with investment grade off-takers, plus energy sales to local power grids. It has approximately 8 operating parks, a total of 44 MWp in operation.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.